Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07550790
NA

Contrast-Induced Acute Kidney Injury Prevention in Acute Heart Failure

Sponsor: Jin Joo Park

View on ClinicalTrials.gov

Summary

The K-PROSE study is a randomized clinical investigation evaluating strategies to prevent contrast-induced acute kidney injury (CI-AKI) in patients hospitalized with acute heart failure and moderate renal dysfunction (eGFR 30-75 mL/min/1.73 m²). Patients requiring contrast-enhanced CT imaging are randomized to either standard intravenous saline hydration or a furosemide-based decongestion strategy. Renal function is assessed using serial measurements of creatinine and cystatin C, before and after contrast exposure. By comparing renal outcomes, congestion status, and safety profiles, this study aims to determine whether a decongestion-focused approach provides superior renal protection compared with conventional hydration in high-risk acute heart failure patients.

Official title: Contrast-Induced Acute Kidney Injury in Acute Heart Failure With Renal Dysfunction: The Kidney Protection Strategies Evaluation in Acute Heart Failure (K-PROSE)

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

190

Start Date

2026-07-01

Completion Date

2027-06-30

Last Updated

2026-07-16

Healthy Volunteers

No

Interventions

DRUG

Furosemide

Intravenous furosemide administered to promote diuresis as part of a decongestion-based renal protection strategy.

DRUG

0.9 % Normal Saline

Intravenous isotonic saline administered as standard hydration for the prevention of contrast-induced acute kidney injury.

Locations (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea